Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / AmbioPharm
Entity

AmbioPharm

Tracked across 1 events · 7 articles · First seen May 27, 2026 · Last active May 27, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Business
CordenPharma acquires AmbioPharm
CordenPharma, a global Contract Development and Manufacturing Organization (CDMO), has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide API CDMO with facilities in North Augusta, South Carolina (United States) and Shanghai (China). This…
Impact: AmbioPharm is being acquired by CordenPharma, which will integrate its peptide manufacturing capabilities and facilities into CordenPharma's global network, allowing its shareholders to reinvest in the combined business.
May 27, 2026 · 7 articles
Key Actions (4)
100 CordenPharma entered agreement to acquire AmbioPharmCordenPharma acquires AmbioPharm
70 AmbioPharm reinvested into CordenPharmaCordenPharma acquires AmbioPharm
50 The Carlyle Group worked closely with AmbioPharmCordenPharma acquires AmbioPharm
10 BNP Paribas acted as advisor AmbioPharmCordenPharma acquires AmbioPharm
NEWSDESK
Track AmbioPharm live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.